1. A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC). Issue 4 (1st June 2003) Authors: Bacon, M.; James, K.; Zee, B. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 4(2003) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer. (1st October 2003) Authors: Piccart, M. J.; Bertelsen, K.; Stuart, G.; Cassidy, J.; Mangioni, C.; Simonsen, E.; James, K.; Kaye, S.; Vergote, I.; Blom, R.; Grimshaw, R.; Atkinson, R.; Swenerton, K.; Trope, C.; Nardi, M.; Kaern, J.; Tumolo, S.; Timmers, P.; Roy, J.-A.; Lhoas, F. Journal: International journal of gynecological cancer Issue: Volume 13(2003)Supplement 2 Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Discriminative Efficacy of Retinal Characteristics on Two Traditional Chinese Syndromes in Association with Ischemic Stroke. (26th March 2020) Authors: Zhuo, Y. Y.; Wu, J. M.; Kuang, L.; Qu, Y. M.; Zee, B.; Lee, J.; Yang, Z. X. Other Names: Andrade-Cetto Adolfo Academic Editor. Journal: Evidence-based complementary and alternative medicine Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗